According to Ultragenyx Pharmaceutical's latest financial reports the company's current revenue (TTM ) is โน62.35 Billion. an increase over the revenue in the year 2024 that were of โน48.06 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.